NEW YORK, NY / ACCESS Newswire / January 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation on behalf of shareholders of Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS) face uncertain paths forward. They have both undergone management changes and are deploying turnaround strategies, which leaves a lot ...
The U.S. Justice Department said on Friday it has filed a lawsuit alleging that pharmacy chain operator Walgreens knowingly ...
Good morning and thank you for joining us for the Walgreens Boots Alliance earnings call for the first quarter of fiscal year ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Walgreens Boots Alliance (WBA – Research ...
Walgreens' worst day of the year came on June 27, when the stock fell 22% on another disappointing earnings report. This time ...
WBA's fiscal 2025 first-quarter results are expected to continue to reflect a soft U.S. Retail Pharmacy performance.
Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit on Friday and indicated that ...
Looking forward, Walgreens Boots Alliance is maintaining its adjusted EPS (earnings per share) guidance for fiscal 2025 between $1.40 to $1.80. The company expects growth from its U.S. Healthcare and ...
Walgreens Boots Alliance, Inc. (WBA) stock price is 12.52 and Walgreens Boots Alliance, Inc. (WBA) 10-day simple moving average is 10.84. Walgreens Boots Alliance, Inc. (WBA) stock price is 12.52 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback